USD10
CNTB Ações
Sobre Connect Biopharma HldgsConnect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
USD10
CNTB Ações
Sobre Connect Biopharma HldgsConnect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Estatísticas
JANELA DE NEGOCIAÇÃO
Fechado
ABRE ÀS
25 de mar. at 13:30 GMT+0
CAPITALIZAÇÃO DE MERCADO
US$ 169,39 mi
PREÇO ABERTO
Sem dados suficientes
BAIXO (1 A)
US$ 0,51
ALTO (1 A)
US$ 3,28
BAIXO (24H)
US$ 2,90
ALTO (24H)
US$ 3,18
VOLUME (24H)
US$ 1,00
100%
Histórico de preços
Time | Price | Change |
|---|---|---|
Hoje | Sem dados suficientes | Sem dados suficientes |
1 dia | US$ 3,00 |